Suzhou Forlong Biotechnology
As of the edition of 20 October 2026, Suzhou Forlong Biotechnology runs 1 drug.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 1 |
| Total | 1 |
Where its trials are
- Cancer: 1 trials led
- Pregnancy and women's health: 1 trials led
- Urinary and reproductive: 1 trials led